Subscribe for free
Cancerworld
Facebook Twitter LinkedIn

About the Magazine

  • About us
  • Editorial Team
  • Events
  • Archive
  • Contacts

Articles

  • Policy
  • Practice Points
  • Delivery of Care
  • Biology basic
  • Medicine
  • Featured

Contents

  • News
  • Editorials
  • Interviews to the Expert
  • In the Hot Seat
  • Profiles
  • Obituaries
  • Voices

ESO College Corner

  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner

Circulating tumour DNA provides early warning of metastatic breast cancer 
News

Circulating tumour DNA provides early warning of metastatic breast cancer 

In high-risk hormone receptor positive breast cancer circulating tumour DNA (ctDNA) was identified a median of one year before distant metastasis. The study, published in the Journal of Clinical Oncology (4th June,…

By Janet Fricker | Jul 5, 2022
Study defines subset of women benefitting from digital breast tomosynthesis
News

Study defines subset of women benefitting from digital breast tomosynthesis

Digital breast tomosynthesis (DBT) offers an advantage over conventional digital mammography in only a tiny percentage of women, who have extremely dense breasts and a high risk of breast cancer. The cohort…

By Janet Fricker | Jun 24, 2022
It’s a CIN: bringing order to the chaos of cancer chromosome instability
News

It’s a CIN: bringing order to the chaos of cancer chromosome instability

A new framework has been developed for interpreting complex genetic change patterns seen in cancer chromosomal instability (CIN). The computational analysis study, published in Nature (online 15 June), identifies 17 separate ‘signatures’…

By Janet Fricker | Jun 23, 2022
Antibody-drug conjugates make their mark at ASCO
News

Antibody-drug conjugates make their mark at ASCO

Reports of the results of two antibody-drug conjugates (ADCs), one for HER-low metastatic breast cancer, the other for metastatic lung cancer resistant to EGFR inhibitors, highlight the advances being made in this…

By Janet Fricker | Jun 10, 2022
Study shines new light on breast cancer’s sweet tooth
News

Study shines new light on breast cancer’s sweet tooth

Breast cancer cells impair the function of pancreatic islets to make them produce less insulin than required, resulting in higher blood glucose levels in breast cancer patients compared to women without cancer.…

By Janet Fricker | Jun 10, 2022
US study suggests colorectal cancer screening should start at age 45
News

US study suggests colorectal cancer screening should start at age 45

Screening women below the age of 50 for colorectal cancer (CRC) can significantly reduce their risk in comparison to those who have no endoscopic screening or who initiate testing at age 50.…

By Janet Fricker | May 25, 2022
Multicomponent prevention strategy reduces risk of cancer
News

Multicomponent prevention strategy reduces risk of cancer

The combination of high-dose vitamin D, omega-3 and a simple home strength exercise programme (SHEP) reduced the risk of healthy adults aged 70 or older developing cancer by nearly two-thirds. The study, published…

By Janet Fricker | May 20, 2022
Lumpectomy as effective as mastectomy in young breast cancer patients
News

Lumpectomy as effective as mastectomy in young breast cancer patients

Women under 40 with non-metastatic breast cancer experience similar survival regardless of whether they are treated with mastectomy or lumpectomy. The abstract presented at the American Society of Breast Surgeons annual meeting,…

By Janet Fricker | May 13, 2022
Multi organ chip could facilitate personalised cancer therapy 
News

Multi organ chip could facilitate personalised cancer therapy 

A ‘plug-and-play’ multi-organ chip, the size of a microscope slide, could be customised for individual cancer patients to determine personalised therapy. The study, published in Nature Biomedical Engineering, reports for the first…

By Janet Fricker | May 12, 2022
From social determinants to cancer outcomes: the cell biology behind the disparities
Articles

From social determinants to cancer outcomes: the cell biology behind the disparities

Raised levels of stress are a normal response to being diagnosed with cancer, and asking patients about their psychological and emotional wellbeing is, or should be, a normal part of attending to…

By Janet Fricker | Apr 29, 2022
    « 1 … 13 14 15 16 17 … 24 »

Subscribe free to Cancerworld

Fortnightly features, news and analysis — straight to your inbox.

Subscribe Now

About the Magazine

  • About us
  • Editorial Team
  • Events
  • Archive
  • Contacts
  • ESO College Corner

Articles

  • Policy
  • Practice Points
  • Delivery of Care
  • Biology basic
  • Medicine
  • Featured

Contents

  • News
  • Editorials
  • Interviews to the Expert
  • In the Hot Seat
  • Profiles
  • Obituaries
  • Voices
Cancerworld
About us Articles Media Corner Privacy Policy Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.)  |  Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States  |  [email protected]